Huvexxin 100 mg/ml solution for injection for cattle, pigs and sheep
Huvexxin 100 mg/ml solution for injection for cattle, pigs and sheep
Authorised
- Tulathromycin
Product identification
Medicine name:
Huvexxin 100 mg/ml solution for injection for cattle, pigs and sheep
Huvexxin, 100 mg/mL, otopina za injekciju, za goveda, svinje i ovce
Active substance:
- Tulathromycin
Target species:
-
Sheep
-
Pig
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Tulathromycin100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Sheep
-
Meat and offal16day
-
- Pig
-
Meat and offal13day
-
-
Subcutaneous use
- Cattle
-
Meat and offal22day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA94
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Type I colourless glass vial with a chlorobutyl rubber stopper and an aluminium overseal. Pack sizes: Cardboard box containing one vial of 100 ml.
- Type I colourless glass vial with a chlorobutyl rubber stopper and an aluminium overseal. Pack sizes: Cardboard box containing one vial of 20 ml.
- Type I colourless glass vial with a chlorobutyl rubber stopper and an aluminium overseal. Pack sizes: Cardboard box containing one vial of 250 ml.
- Type I colourless glass vial with a chlorobutyl rubber stopper and an aluminium overseal. Pack sizes: Cardboard box containing one vial of 50 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet J.S.C.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/22-01/718
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0662/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 2/02/2024
How useful was this page?: